2013
DOI: 10.1074/jbc.m112.435123
|View full text |Cite
|
Sign up to set email alerts
|

Mammalian Target of Rapamycin (mTor) Mediates Tau Protein Dyshomeostasis

Abstract: Background: Perturbations of the mammalian target of rapamycin (mTor) signaling pathway are implicated in Alzheimer disease (AD). Results:The activated mTor alters the activity of major tau kinases contributing to the formation of tau dyshomeostasis. Conclusion:We established a cellular system using genetic activation of mTor that developed authentic AD-like changes. Significance: The study provides potential tools for identifying tau-based therapeutics.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
105
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 114 publications
(108 citation statements)
references
References 73 publications
3
105
0
Order By: Relevance
“…Therefore, it is possible that targeted inhibition of CDK9, CDK7, P70S6K, or the specific mRNAs regulated by P70S6K may prevent neuronal loss. On the basis of our data and the finding that P70S6K activation induces Tau hyperphosphorylation and tangle formation (65,72), we hypothesize that inhibition of P70S6K may not only prevent apoptosis but also protect neurons from microtubule destabilization and neurodegeneration. An identification of the mRNAs regulated by P70S6K may provide us with more insights into their role in apoptosis, and these mRNAs could be targeted to prevent neurodegeneration and neuronal loss associated with various neurodegenerative diseases.…”
Section: Discussionmentioning
confidence: 96%
“…Therefore, it is possible that targeted inhibition of CDK9, CDK7, P70S6K, or the specific mRNAs regulated by P70S6K may prevent neuronal loss. On the basis of our data and the finding that P70S6K activation induces Tau hyperphosphorylation and tangle formation (65,72), we hypothesize that inhibition of P70S6K may not only prevent apoptosis but also protect neurons from microtubule destabilization and neurodegeneration. An identification of the mRNAs regulated by P70S6K may provide us with more insights into their role in apoptosis, and these mRNAs could be targeted to prevent neurodegeneration and neuronal loss associated with various neurodegenerative diseases.…”
Section: Discussionmentioning
confidence: 96%
“…Data are presented as means Ϯ SEM and were analyzed by one-way ANOVA; *p Ͻ 0.05. Caccamo et al, 2013;Tang et al, 2013). Thus, mTOR might represent a molecular link between A␤ accumulation and tau pathology.…”
Section: Discussionmentioning
confidence: 99%
“…It acts in vitro as expected from an mTORC1 inhibitor on tau phosphorylation [75][76][77]. Rapamycin decreases tau levels (total and phosphorylated) in a cellular assay [78], possibly acting on translation and autophagy. It reduces tau neurotoxicity in R406W mutant tau-carrying Drosophila flies [47].…”
Section: Mtorc1mentioning
confidence: 97%